Want to join the conversation?
$AGN now expects 2016 GAAP net revenues of $14.65-14.9Bil and branded net revenues of $14.75-15Bil. $AGN expects selling, general and administrative expense of about $4.4Bil, research and development expense of about $2.1Bil and net interest expense of about $1.2Bil. $AGN sees 2016 loss per share of $1.95-2.15 and tax rate of about 57%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.